Subsequently, we further analyzed the interactions between identified target proteins (HSPA1A, SERPINA1, and DAPK1) and chemotherapy drugs (camptothecin, mitoxantrone, paclitaxel, and rapamycin) of COAD using molecular docking techniques. This evidence concerns the gene SERPINA1 and colon adenocarcinoma.